【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 9
2 Introduction 10
2.1 What Is This Report About? 10
3 Definitions of Markets/Categories Covered 11
3.1 Orthopedic Devices 11
3.1.1 Arthroscopy 11
3.1.2 Spinal Surgery 11
4 Company Snapshot 12
4.1 Key Key Facts 12
4.2 Company Overview 12
4.3 Financial Performance 12
4.4 SWOT Snapshot 12
5 Business Description 13
5.1 Business Overview 13
5.2 Other 13
5.2.1 Overview 13
5.2.2 Financials 13
5.2.3 Market View 13
5.3 Sports Medicine 14
5.3.1 Overview 14
5.3.2 Financials 14
5.3.3 Market View 14
5.4 Major Products and Services 14
5.4.1 Overview 14
6 History 16
7 Business Strategy 18
7.1 Mission Statement 18
8 SWOT Analysis 19
8.1 Overview 19
8.2 ArthroCare Corporation Strengths 19
8.2.1 Focus on Research and Development Activities 19
8.2.2 Proprietary Coblation Technology 19
8.2.3 Diversified Operations 20
8.3 ArthroCare Corporation Weaknesses 20
8.3.1 Dependence on the US Market 20
8.3.2 Governmental Investigations 20
8.3.3 Decline in Current Asset Turnover 21
8.4 ArthroCare Corporation Opportunities 21
8.4.1 Product Approvals 21
8.4.2 Growth in Arthroscopy Market 21
8.4.3 Growing Spinal Surgery Procedures 21
8.4.4 Market Growth in Emerging Economies 22
8.5 ArthroCare Corporation Threats 22
8.5.1 Stringent Government Regulations 22
8.5.2 Competitive Landscape 22
8.5.3 Dependent on Few Suppliers 22
8.5.4 Growing Consolidation in the Industry 22
9 Competitors 23
10 Competitive Landscape 24
10.1 Orthopedic Devices (Spinal Surgery), Global, Market Share (%), 2011 24
10.2 ArthroCare Corporation, Orthopedic Devices (Spinal Surgery), by Region, Market Share (2011) 26
10.3 ArthroCare Corporation, Orthopedic Devices (Spinal Surgery), by Country, Market Share (2011) 27
10.4 Orthopedic Devices (Arthroscopy), Global, Market Share (%), 2011 28
10.5 ArthroCare Corporation, Orthopedic Devices (Arthroscopy), by Region, Market Share (2011) 29
10.6 ArthroCare Corporation, Orthopedic Devices (Arthroscopy), by Country, Market Share (2011) 30
11 Share Holding Structure 32
12 Key Employees 33
13 Key Employee Biographies 34
14 Company Statement 35
15 Locations And Subsidiaries 38
15.1 Head Office 38
15.2 Other Locations & Subsidiaries 38
16 Financial Deals Landscape 40
16.1 ArthroCare Corporation, Deals Volume Summary, 2007 to YTD 2013 40
17 ArthroCare Corporation, Deals Summary By Region, 2007 to YTD 2013 41
18 ArthroCare Corporation Detailed Deal Summary 43
18.1 Partnerships 43
18.1.1 Wright Medical Enters Into Distribution Agreement With ArthroCare 43
18.2 Equity Offering 44
18.2.1 ArthroCare Completes Private Placement Of $75 Million 44
18.3 Asset Transactions 46
18.3.1 NeuroTherm Acquires Parallax And Contour Product Lines From ArthroCare 46
18.4 Acquisition 47
18.4.1 ArthroCare Acquires OrtoConcept 47
18.4.2 ArthroCare Acquires DiscoCare 48
19 Recent Developments 49
19.1 Financial Announcements 49
19.1.1 Oct 31, 2012: ArthroCare Reports Revenue Of $86.9m In Q3 2012 49
19.1.2 Aug 01, 2012: ArthroCare Reports Revenue Of $91.7m In Q2 2012 50
19.1.3 May 02, 2012: ArthroCare Reports Revenue Of $92.9m In Q1 2012 51
19.1.4 Feb 16, 2012: ArthroCare Reports Revenue Of $354.9m In 2011 52
19.1.5 Nov 02, 2011: ArthroCare Reports Revenues Of $83.3m In Q3 2011 54
19.1.6 Aug 03, 2011: ArthroCare Reports Total Revenue Of $91.3m In Q2 2011 55
19.1.7 May 02, 2011: ArthroCare Reports Total Revenue Of $87.9m In Q1 2011 56
19.1.8 Feb 14, 2011: ArthroCare Reports Total Revenues Of $355.38m In 2010 58
19.1.9 Nov 01, 2010: ArthroCare Reports Net Income Of $9.26 Million For Q3 2010 58
19.1.10 Aug 03, 2010: ArthroCare Reports Net Income Of $7.27 Million In Q2 2010 59
19.1.11 May 05, 2010: ArthroCare Reports Net Income Of $8.8 Million In Q1 2010 60
19.1.12 Mar 15, 2010: ArthroCare Reports Total Revenues Of $331.6 Million In 2009 61
19.1.13 Nov 24, 2009: ArthroCare Reports Total Revenues Of $79.5 Million In Q3 2009 62
19.1.14 Nov 19, 2009: ArthroCare Reports Revenue Of $80.8 Million For Q2 2009 64
19.1.15 Apr 21, 2008: ArthroCare Declares Q1 2008 Results 64
19.1.16 Feb 26, 2008: ArthroCare Board Extends Share Repurchase Plan 66
19.1.17 Feb 19, 2008: ArthroCare Declares Q4 2007 Results 66
19.1.18 Oct 22, 2007: ArthroCare Declares Q3 2007 Results 68
19.1.19 Jul 26, 2007: ArthroCare Declares Q2 2007 Results 70
19.1.20 Apr 26, 2007: ArthroCare Q1 Revenue Up 18% To $73.7 Million 71
19.1.21 Feb 15, 2007: ArthroCare Q4 Revenue Up 18% To $69.8 Million 71
19.1.22 Jan 09, 2007: ArthroCare Sees Q4 2006 Revenues At $69.7 Million 73
19.1.23 Oct 26, 2006: ArthroCare Q3 2006 Total Revenue Up 21% To $64.7 Million 74
19.1.24 Aug 03, 2006: ArthroCare Q2 2006 Revenue Up 28% To $51.7 Million 75
19.2 Corporate Communications 78
19.2.1 Jan 19, 2010: ArthroCare Shares To Begin Trading Oon NASDAQ Global Market 78
19.2.2 Jan 04, 2010: ArthroCare Appoints Scott Schaffner As Senior Vice President And General Manager Of Sports Medicine 78
19.2.3 Oct 26, 2009: ArthroCare Appoints David Fitzgerald As President, CEO 78
19.2.4 Jul 01, 2009: ArthroCare Appoints Andrew Miclot As SVP, General Manager Of ENT Business 79
19.2.5 Apr 02, 2009: ArthroCare Names Todd Newton As Senior Vice President, CFO 79
19.2.6 Feb 18, 2009: ArthroCare Announces Management Changes 80
19.2.7 Jan 15, 2009: ArthroCare Gets Nasdaq Delisting Notice 80
19.2.8 Dec 19, 2008: ArthroCare Announces Management Resignations 80
19.2.9 Dec 19, 2008: ArthroCare Announces Senior Management Promotions 81
19.2.10 Dec 01, 2008: ArthroCare Announces Decision From NASDAQ Granting Its Request For Continued Listing 81
19.2.11 Nov 18, 2008: ArthroCare Receives Deficiency Notice From Nasdaq 81
19.2.12 Dec 14, 2006: ArthroCare Expands Board 82
19.3 Legal and Regulatory 82
19.3.1 Aug 22, 2012: Two Former Senior Executives of ArthroCare Arrested In $400m Securities Fraud Scheme 82
19.3.2 Nov 28, 2011: ArthroCare Announces Agreement In Principle To Settle Securities Class Action 84
19.3.3 Feb 09, 2011: ArthroCare Announces Settlement Of SEC Investigation 84
19.3.4 Mar 04, 2010: Arthrocare Enters Settlement Agreement With Nationwide In Reimbursement Dispute 84
19.3.5 Dec 08, 2009: ArthroCare To Pay About $1 Million To Settle With Several Insurers Over SpineWand Reimbursement Claims 85
19.3.6 Feb 18, 2009: ArthroCare Announces Investigations By SEC And US Attorney Offices 85
19.3.7 Jul 24, 2008: ArthroCare Says SEC Starts Informal Inquiry Into Accounting Practices After Restatement 85
19.3.8 Apr 07, 2008: Sarraf Files Lawsuit Against ArthroCare 85
19.4 Product News 86
19.4.1 Aug 15, 2011: ArthroCare Receives FDA Clearance For SpeedLock Knotless Fixation Device 86
19.4.2 Jul 26, 2011: ArthroCare Receives FDA Clearance For SpeedFix Suture System 86
19.4.3 Jun 06, 2011: ArthroCare Receives FDA Clearance For Spartan 6.5 Needled Suture Implant 86
19.4.4 Feb 22, 2011: ArthroCare Receives FDA Clearance For Parallax Contour -Enhanced Vertebral Augmentation Device 87
19.4.5 Feb 15, 2011: ArthroCare Receives FDA Clearance For Spartan 5.5 Needled Suture Implant 87
19.4.6 Dec 09, 2010: ArthroCare Receives CE Mark Approval For WoundWand Debridement Device 87
19.4.7 Nov 02, 2010: ArthroCare Receives FDA Clearance For SpeedFix 87
19.4.8 Oct 28, 2010: ArthroCare Receives FDA Clearance For Spartan PEEK Suture Implant 88
19.4.9 Sep 24, 2010: ArthroCare Receives FDA Clearance For Parallax Contour Vertebral Augmentation Device 88
19.4.10 Sep 24, 2008: New Studies Highlight Benefits Of Coblation-Assisted Procedures In Airway Fire Prevention And Endoscopic Sinus Surgery 88
19.4.11 Jun 23, 2008: Two Studies At World Oncology Conference Support ArthroCare SpineWand 89
19.4.12 Jun 19, 2008: ArthroCare Corporation (ARTC) Launches DoublePlay New Osteoconductive Suture Anchor 89
19.4.13 Jun 19, 2008: ArthroCare Corporation (ARTC) Sets New Standard In Modern Arthroscopy Launches New Quantum Pump Arthroscopy System 90
19.4.14 May 07, 2008: Patients Treated For Chronic Tendinosis With TOPAZ Highly Satisfied Study Shows 90
19.4.15 Apr 10, 2008: ArthroCare Announces Parallax Contour, A New Device For Mechanical Void Creation 91
19.4.16 Apr 03, 2008: ArthroCare Unveils New Direction In Treatment Of Metastatic Lesions 91
19.4.17 Oct 30, 2007: ArthroCare Launches Opus TwinLock Knotless Fixation System 92
19.4.18 Oct 23, 2007: ArthroCare Releases New SpineWand For Less Invasive Spinal Surgeries 92
19.4.19 May 22, 2007: Two Studies Indicate Coblation Safely Treats Symptomatic Chondral Defects in the Knee 92
19.4.20 May 15, 2007: ArthroCare Receives FDA Clearance to Treat Malignant Lesions in the Spine 93
19.4.21 Apr 26, 2007: ArthroCare Receives FDA Clearance To Market Magnum PI Knotless Implant System 93
19.4.22 Apr 27, 2006: Study Results Show Coblation Technology Preserves Same Amount of Healthy Cells as Mechanical Shaver in Treatment of Meniscus 93
19.4.23 Mar 30, 2006: ArthroCare Receives FDA Clearance for Latest Vertebroplasty Innovation to Help Treat Vertebral Compression Fractures 94
19.4.24 Aug 03, 2005: ArthroCare’s TOPAZ Named Among Podiatry Today’s Annual Top Ten Innovations List. 94
19.4.25 Nov 03, 2004: Live Webcast On Minimally Invasive Tendon And Fascia Treatments To Feature ArthroCare’s TOPAZ Microdebrider 94
19.4.26 Apr 28, 2004: ArthroCare introduced two new SpineWands 94
19.4.27 Oct 15, 2003: Bilok(R) for ACL Fixation Now Available in United States 95
19.4.28 Apr 01, 2000: Arthrocare’s Coblation System To Be Used For Brain Surgery 95
19.5 Product Approvals 95
19.5.1 Aug 15, 2011: ArthroCare Receives FDA Clearance For SpeedLock Knotless Fixation Device 95
19.5.2 Jul 26, 2011: ArthroCare Receives FDA Clearance For SpeedFix Suture System 95
19.5.3 Jun 06, 2011: ArthroCare Receives FDA Clearance For Spartan 6.5 Needled Suture Implant 96
19.5.4 Feb 22, 2011: ArthroCare Receives FDA Clearance For Parallax Contour -Enhanced Vertebral Augmentation Device 96
19.5.5 Feb 15, 2011: ArthroCare Receives FDA Clearance For Spartan 5.5 Needled Suture Implant 96
19.5.6 Dec 09, 2010: ArthroCare Receives CE Mark Approval For WoundWand Debridement Device 97
19.5.7 Nov 02, 2010: ArthroCare Receives FDA Clearance For SpeedFix 97
19.5.8 Oct 28, 2010: ArthroCare Receives FDA Clearance For Spartan PEEK Suture Implant 97
19.5.9 Sep 24, 2010: ArthroCare Receives FDA Clearance For Parallax Contour Vertebral Augmentation Device 97
19.5.10 May 15, 2007: ArthroCare Receives FDA Clearance to Treat Malignant Lesions in the Spine 98
19.5.11 Apr 26, 2007: ArthroCare Receives FDA Clearance To Market Magnum PI Knotless Implant System 98
19.5.12 Mar 30, 2006: ArthroCare Receives FDA Clearance for Latest Vertebroplasty Innovation to Help Treat Vertebral Compression Fractures 98
19.6 Clinical Trials 99
19.6.1 Sep 24, 2008: New Studies Highlight Benefits Of Coblation-Assisted Procedures In Airway Fire Prevention And Endoscopic Sinus Surgery 99
19.6.2 May 07, 2008: Patients Treated For Chronic Tendinosis With TOPAZ Highly Satisfied Study Shows 99
20 Appendix 101
20.1 Research Methodology 102
20.2 Secondary Research 102
20.3 Primary Research 102
20.4 Models 103
20.5 Forecasts 103
20.6 Expert Panels 103
20.7 GlobalData Consulting 103
20.8 Currency Conversion 104
20.9 Contact Us 105
20.10 Disclaimer 105
【レポート販売概要】
■ タイトル：ArthroCare Corporation：市場シェア分析■ 英文：ArthroCare Corporation Market Share Analysis
■ 発行日：2013年2月28日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160473
■ 調査対象地域：グローバル
- カナダのエレベータ/エスカレータ市場About elevators and escalators Elevators and escalators are deployed in buildings for the smooth and easy movement of people and goods within a building's premises. They are installed in commercial, residential, and mixed-used buildings. They are also installed in public places to improve vehicle parking management. Technavio's analysts forecast the elevator and escalator market in Canada to grow …
- P-キシレン(PX)の世界市場予測P-xylene 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about p-xylene market in the all-in-one report issued in a logical and easily accessible format. In addition to the analytical part, the re …
- 世界の永久磁石モ—タ市場2015The Global Permanent Magnet Motor Industry Report 2015 is a professional and in-depth study on the current state of the Permanent Magnet Motor industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Permanent Magnet Motor market analysis is provided for the international markets including development trend …
- ノロウイルス・ワクチンの世界市場機会分析Noroviruses (NVs) called "Norwalk-like viruses" are a group of single-stranded positive sense RNA viruses and members of the family Caliciviridae. NVs are transmitted from human-to-human and are one of the most highly infectious viruses known. In the community, NVs most commonly cause a self-limiting mild disease of short duration with gastrointestinal symptoms usually resolving after 1 to 3 days. …
- 2014年戦略提言：世界の性行為感染症（STD）診断検査市場Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.This new 350-page report from Venture Planning Group contains 90 tables and provides analysis of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. T …
- 神経根症(Radiculopathy)：世界の治験レビュー（2015年上半期版）Radiculopathy Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Radiculopathy Global Clinical Trials Review, H1, 2015" provides data on the Radiculopathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Radiculopathy. It includes an overview of the trial numbers and their recruitment status as per the …
- Jackson Electric Membership Corporation：発電所及びSWOT分析2013Jackson Electric Membership Corporation - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (asse …
- EPS（電動パワーステアリング）の世界市場：コラム式、ピニオン式、ラック式電動パワーステアリングAbout Electric Power Steering System EPS systems are rapidly gaining acceptance among automakers and consumers because of the benefits they offer. They are lightweight and offer more fuel economy, when compared with hydraulic power steering systems. In terms of precision, EPS systems are more precise and reduce the steering effort. TechNavio's analysts forecast the Global Electric Power Steering m …
- マーケティング・広告産業向けモバイルAR（拡張現実）の世界市場About Mobile AR AR is an emerging technology that blends digital content with the physical world. It is used to display computer-generated images in a user’s field of vision to provide relevant information about objects in the real world. It allows a user to scan the physical real world environment and provides an enhanced or augmented experience by adding virtual computer-generated information. E …
- 世界の航空・防衛産業における数値流体力学(CFD)ソフトウェア市場About CFD Software CFD is a tool that analyzes the flow, turbulence, pressure distribution, and interaction of fluids with structures by using numerical simulations based on Navier-Stokes equation. It is the science predicting fluid flow, mass transfer, chemical reactions, and related phenomenon. CFD technology uses high-speed computers, numerical methods, and solvers to simulate the flow of fluid …
- モバイルユーザー認証の世界市場Today, most of enterprises are vying to effectively address the security and the authentication concerns attributed to verify the end-users and legitimize his/her actions. The end-users are becoming highly aware of the security aspect and most of the software providers are incorporating security into their service level agreements. But major boost to the need of strong authentication is attributed …
- フラッキング（水圧破砕法）流体及び化学薬品の世界市場2017-2021About Fracking Fluid and Chemicals Fracking fluids are a complex mixture of chemicals, water, and sand. The composition of fracking fluids is unique to each company; they alter the composition of fracking fluids depending on the presence of groundwater or surface water. The selection of the fracking fluid mix is also dependent on the region and guidelines mandated by local and state governments. T …
- Neon Energy Limited：石油・ガスの開発・生産動向及びコスト分析– 2012Neon Energy Limited Oil & Gas Exploration and Production Operations and Cost Analysis – 2012 Summary Neon Energy Limited Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key …
- 世界の医療用インプラント市場動向：整形外科用インプラント、心臓血管インプラント、歯科用インプラント、眼科用インプラントMedical Implant, an innovative technique to prevent chronic pain has been growing, swiftly across the globe over the past few years and presenting ample growth opportunities to the industry players. With favorable demographics, positive eco-financial dynamics, and rising awareness, the global medical implant market is poised to scale newer acmes. Moreover, augmented M&A activity in the industry, i …
- 世界の合法的通信傍受市場：ネットワーク技術別、傍受デバイス別、通信コンテンツ別、サービス別分析For the purpose of evidences and analysis, intercepting a private communication has become very essential. The need for preventing terrorism and criminal activities has also raised a lot. Earlier, criminals had an easy way to communicate and intercepting a simple phone call was quite uncomplicated with the help of wire-tapping. Since the advancement of communication channels and technologies over …
